American Well Corporation Class A Common Stock (AMWL)

BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSEAMWL), a leader in technology-enabled care, today announced that, on March 3, 2025, it made a grant of restricted stock units (“RSUs”) covering 220,844 shares of its Class A common stock to Dan Zamansky. The grant was offered as material inducement to Zamansky’s employment as Amwell’s chief product and technology officer. The RSUs become vested as follows, subject to Zamansky’s continued employment through each vesting date, except as noted below: 25% of the RSUs will vest on the six-month anniversary of the grant date (“Initial Vesting Date”), and the remaining 75% of the RSUs will vest in equal pro-rata increments every three (3) months thereafter (beginning on the first calendar day of the month following the date that is three months following the Initial Vesting Date) until such RSUs are fully vested on the first day of the calendar month following the four (4) year anniversary of the grant date. If Zamansky’s employment is terminated by the company without cause or by Zamansky with good reason, conditioned on Zamansky’s execution and non-revocation of a release of claims, the aforementioned grant will vest as to the portion that would have vested had Zamansky remained employed by the company through the first anniversary of his termination date. In addition, if the involuntary termination of employment occurs one month before or within 24 months following a change in control, the aforementioned grant will fully vest at the time of termination.

Amazon veteran Dan Zamansky joins company’s executive team

BOSTON, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSEAMWL), a leading technology-enabled care platform provider, announced that on Feb. 18, Amwell made grants of RSUs covering an aggregate of 16,737 shares of its Class A common stock to four new employees. The grants were offered as material inducement to the employees’ employment with Amwell. The RSUs will vest as follows, subject to the applicable employee’s continued employment through the applicable vesting date: 25% of the RSUs will vest upon the first anniversary of the grant date (“Initial Vesting Date”), and the remaining 75% of the RSUs will vest in equal pro rata increments every three months thereafter (beginning on the first calendar day of the month following the date that is three months following the Initial Vesting Date) for three years until such RSUs are vested in full.

BOSTON, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSEAMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, will participate in an upcoming investor conference. Ido Schoenberg, M.D., Amwell chairman and chief executive officer, will participate in a fireside chat and one-on-one meetings at the TD Cowen 24th Annual Health Care conference in Boston on March 4. The fireside chat will be at 9:10 a.m. ET and an audio webcast of the fireside chat will be available at investors.amwell.com.

BOSTON, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSEAMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the fourth quarter and full year ended Dec. 31, 2024. Visit Amwell’s investor relations website at investors.amwell.com to view the fourth quarter and full year 2024 earnings report.

BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSEAMWL), a leader in digital care, will report fourth quarter 2024 operating results after stock market trading hours on Wednesday, Feb. 12.

Vida to offer cardiometabolic solutions including GLP-1s and other anti-obesity medications on the Amwell platform

SIOUX FALLS, SD / ACCESSWIRE / January 9, 2025 / Avel eCare, the nation's leading telemedicine provider of clinician-to-clinician services, is proud to announce the acquisition of Amwell Psychiatric Care (APC), a division of Amwell® (NYSEAMWL). This acquisition further solidifies Avel eCare's position as a national leader in telemedicine and expands its Behavioral Health services to meet the growing demand across rural and urban communities.

Divestment of Amwell Psychiatric Care intended to focus product portfolio on key growth initiatives

Seasoned leader assumes responsibility for operations and sales as COO

BOSTON, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSEAMWL) a small-cap, growth healthcare company and a leading provider of healthcare software as a service, today announced financial results for the third quarter ended Sept. 30, 2024. Visit Amwell’s investor relations website at investors.amwell.com to view the third quarter 2024 earnings report.

BOSTON, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSEAMWL), a leader in digital care, today announced that, on November 4, 2024, it made a grant of restricted stock units (“RSUs”) covering 254,227 shares of its Class A common stock to Mark Hirschhorn. The grant was offered as material inducement to Mr. Hirschhorn’s employment as Amwell’s chief financial officer. The RSUs become vested as follows, subject to Mr. Hirschhorn’s continued employment through each vesting date, except as noted below: 25% of the RSUs vested on the grant date, and the remaining 75% of the RSUs will vest in substantially equal quarterly installments over a three-year period, starting on the one-year anniversary of the grant date, with the first vesting date for the remaining 75% portion occurring on the first day of the first month following the 15-month anniversary of the grant date and with subsequent vesting dates occurring on each three-month anniversary thereof until such RSUs are fully vested on the four-year anniversary of the grant date. In addition, Mr. Hirschhorn is eligible for an additional grant with a total value of up to $5,000,000. The additional grant will vest in substantially equal annual installments on each of the first four anniversaries of Mr. Hirschhorn’s employment start date, provided that Mr. Hirschhorn remains employed by the company through the applicable vesting date and applicable EBITDA targets and appreciation of company valuation targets, in each case, as determined by Amwell’s board of directors or the compensation committee of the board of directors in its sole discretion, are achieved. The additional grant, to the extent it becomes vested, will be settled in cash, unless and to the extent the board of directors or the compensation committee of the board of directors determines in its sole discretion that it will be settled in shares of Class A common stock or other property. As set forth in Mr. Hirschhorn’s employment agreement, if Mr. Hirschhorn’s employment is terminated by the company without cause or by Mr. Hirschhorn with good reason, conditioned on Mr. Hirschhorn’s execution and non-revocation of a release of claims, the aforementioned grants will vest as to the portion that would have vested had Mr. Hirschhorn remained employed by the company through the first anniversary of his termination date. In addition, if the involuntary termination of employment occurs one month before or within 24 months following a change in control, the aforementioned grants will fully vest at the time of termination.

BOSTON, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSEAMWL), a leader in digital care, announced company leaders will participate in several upcoming investor conferences. Ido Schoenberg, M.D., Amwell chairman and chief executive officer, and Mark Hirschhorn, Amwell chief financial officer, will participate in fireside chats or one-on-one meetings at these events:

Industry veteran Mark Hirschhorn joins Amwell leadership team

BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSEAMWL), a leader in digital care, will report third quarter 2024 operating results on Wednesday, Oct. 30.

Hello Heart selects Amwell platform to extend its reach across patient populations

Boston, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSEAMWL), a leader in hybrid care enablement, announced that the company will participate in several investor conferences in September.

Doximity Inc. (NYSEDOCS) is a digital professional medical networking platform that is a cross between LinkedIn and Meta Platforms Inc.

Boston, July 31, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSEAMWL) a small-cap, growth healthcare company and a leading provider of healthcare software as a service, today announced financial results for the second quarter ended June 30, 2024. Visit Amwell’s investor relations website at investors.amwell.com to view the second quarter 2024 earnings report.

Virtual healthcare provider Teladoc Health Inc. (NYSETDOC) stock is trading down 57.8% year-to-date (YTD). The collapse occurred after reporting Q4 2023

Boston, July 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSEAMWL), a leader in hybrid care enablement, will report its second quarter 2024 operating results on Wednesday, July 31.

Boston, June 28, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSEAMWL), a small-cap growth healthcare company and a leading provider of healthcare software as a service, today announced that its Board of Directors (the “Board”) has approved a 1-for-20 reverse stock split (“Reverse Split”) of its Class A common stock, Class B common stock and Class C common stock (collectively, the “Common Stock”), that is expected to become effective on July 10, 2024 at 5:00 p.m. EDT. The shares of the Company’s Class A common stock are expected to begin trading on the New York Stock Exchange (“NYSE”) on a split-adjusted basis at the market open on July 11, 2024. No change will be made to the trading symbol for the Company’s shares of Class A common stock, “AMWL”, in connection with the Reverse Split. 

Boston, June 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSEAMWL), a leader in hybrid care enablement, today announces the appointment of Ricky Goldwasser to the company's Board of Directors, effective June 13.

Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibility

Him & Hers Health Inc. (NYSEHIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatments